Durable Remission of Metastatic Renal Cell Carcinoma With Gemcitabine and Capecitabine After Failure of Targeted Therapy

by Richey, Stephen L., Ng, Chaan, Lim, Zita D., Jonasch, Eric, Tannir, Nizar M.
Published in J Clin Oncol (2011)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

by Shah, Amishi Y., Karam, Jose A., Lim, Zita D., Ng, Chaan S., Tannir, Nizar M.
Published in Urol Case Rep (2015)

Phase II trial of Pemetrexed plus Gemcitabine in patients with advanced non-clear cell renal cell carcinoma

by Richey, Stephen L, Tamboli, Pheroze, Ng, Chaan S, Lin, E, Lim, Zita D, Araujo, John C, Jonasch, Eric, Sharma, Padmanee, Pagliaro, Lance C, Tannir, Nizar M
Published 2013

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial

by Tannir, Nizar M., Msaouel, Pavlos, Ross, Jeremy A., Devine, Catherine E., Chandramohan, Anuradha, Nogueras Gonzalez, Graciela M., Wang, Xuemei, Wang, Jennifer, Corn, Paul G., Lim, Zita D., Pruitt, Lisa, Karam, Jose A., Wood, Christopher G., Zurita, Amado J.
Published in Eur Urol Oncol (2019)

Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study

by Shah, Amishi Y., Karam, Jose A., Malouf, Gabriel G., Rao, Priya, Lim, Zita D., Jonasch, Eric, Xiao, Lianchun, Gao, Jianjun, Vaishampayan, Ulka N., Heng, Daniel Y., Plimack, Elizabeth R., Guancial, Elizabeth A., Fung, Chunkit, Lowas, Stefanie R., Tamboli, Pheroze, Sircar, Kanishka, Matin, Surena F., Rathmell, W. Kimryn, Wood, Christopher G., Tannir, Nizar M.
Published in BJU Int (2016)